OptimizeRx Corp: Form 8-K, filed May 12, 2026
Filed with the SEC on May 12, 2026 and accepted by EDGAR at May 12, 2026, 20:07 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 1.02 Termination of a material agreement
- Item 2.02 Results of operations
- Item 2.03 New direct financial obligation
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001448431-26-000009. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.